Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org
-- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Saturday, July 7, 2012
Read and decide for yourselves, as I am simply the messenger of information.
Honey bee's sting could be used to treat many neurological illnesses including multiple sclerosis (MS). MS is neuron degeneration disease in which mylien sheath around the neurons can be attacked and causes that the messages from the brain not to reach correctly the corresponding muscle.
Having myelin can speed up sending messages 80 times more, due to this degeneration or mylien loss, movement will be disrupted and in extreme cases due to high attacks and tremors, balance will be lost and disabilities may occur. However, chemical and conventional MS drugs might be used to help a patient, slower the disease progression for 40 percent. The medicines which never cure are generally 3 types: 1. Interferon Beta 1a, 2. Interferon Beta 1b, 3.accetate acid and other kinds of medicines. There are other kinds of medicines like Tysabri, Novanterone which kills white blood cells and shortly a patient feels revealed which may cause blood cancer and progressive multifocal leukemia. T- Cells are parts of white blood cells which fight with an infection but in case of MS they attack brain nerves and cerebellum that the message from brain cannot be reached correctly to the organ and this causes disability.
Friday, July 6, 2012
Wednesday, July 4, 2012
Mitt Romney's wife says that multiple sclerosis, a debilitating autoimmune disorder, used to make her feel as though Pac-Man was attacking her — from the inside
Tuesday, July 3, 2012
Monday, July 2, 2012
Applications for Lemtrada™ (alemtuzumab), a potential therapy for MS, have been submitted by Genzyme Corp. to both the U.S. Food and Drug Administration and to European regulators. The potential MS therapy for relapsing MS is already approved to treat leukemia under the name Campath®, and Genzyme executives called results from a second Phase III trial for Lemtrada, released earlier this year, “unprecedented.”
Genzyme's clinical development program for Lemtrada included two Phase III studies in which results for Lemtrada were superior to Rebif® (high dose subcutaneous interferon beta-1a) on clinical and imaging endpoints, including a reduction in relapse rate. In addition, as presented at the 2012 American Academy of Neurology meeting, some patients with pre-existing disability treated with Lemtrada in the CARE-MS II trial were more than twice as likely to experience a sustained reduction in disability over two years than patients treated with Rebif.
Side effects of Lemtrada include potential autoimmune illnesses, including thyroid disorders and disorders in which the immune system attacks blood platelets, which can cause bleeding.
The drug is given by daily infusion for five days, and then daily infusion for three days, 12 months later.
For more information or to participate, contact Dr. Kim Shifren at 410-704-6239 or email firstname.lastname@example.org.
Sunday, July 1, 2012
Please leave your opinion to this blog posting
Stuart "applauds" Debbie for writing this letter -- CLAP -CLAP